12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the pre-market movements of 12 healthcare stocks on Thursday. Tempest Therapeutics, Neurogene, Geovax Labs, SAB Biotherapeutics, Trevena, and Molecular Partners saw significant gains, while Mustang Bio, Mobile-health Network, Cyclerion Therapeutics, INmune Bio, CNS Pharma, and Praxis Precision Medicine experienced notable declines.
June 20, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Geovax Labs shares rose 28.94% to $2.45 in pre-market trading, showing strong investor interest.
The notable pre-market gain suggests strong investor interest, likely leading to a positive short-term price movement.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Molecular Partners stock rose 22.23% to $9.73 in pre-market trading, showing positive market sentiment.
The significant pre-market increase suggests positive market sentiment, likely resulting in a short-term price rise.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Neurogene shares rose 31.92% to $40.0 in pre-market trading, reflecting positive market sentiment.
The substantial pre-market increase indicates strong investor confidence, likely resulting in a positive short-term price impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SAB Biotherapeutics stock moved up 24.03% to $3.2 in pre-market trading, indicating positive investor sentiment.
The significant pre-market increase suggests positive investor sentiment, likely resulting in a short-term price rise.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Tempest Therapeutics shares rose 32.8% to $3.79 in pre-market trading, indicating strong investor interest.
The significant pre-market gain suggests strong investor interest, likely leading to a positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Trevena stock rose 23.33% to $0.44 in pre-market trading, reflecting strong investor interest.
The notable pre-market gain indicates strong investor interest, likely leading to a positive short-term price movement.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
CNS Pharma stock fell 8.92% to $2.2 in pre-market trading, reflecting negative investor sentiment.
The significant pre-market decline suggests negative investor sentiment, likely leading to a short-term price drop.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Cyclerion Therapeutics stock decreased by 9.05% to $2.01 in pre-market trading, showing negative investor sentiment.
The significant pre-market decline suggests negative investor sentiment, likely leading to a short-term price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
INmune Bio shares declined by 8.97% to $7.01 in pre-market trading, indicating negative market sentiment.
The notable pre-market decline indicates negative market sentiment, likely resulting in a short-term price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Mustang Bio stock fell 27.4% to $0.62 in pre-market trading, indicating negative investor sentiment.
The significant pre-market decline suggests negative investor sentiment, likely leading to a short-term price drop.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Mobile-health Network shares declined by 9.25% to $1.32 in pre-market trading, reflecting negative market sentiment.
The notable pre-market decline indicates negative market sentiment, likely resulting in a short-term price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Praxis Precision Medicine shares decreased by 8.65% to $34.43 in pre-market trading, showing negative market sentiment.
The notable pre-market decline indicates negative market sentiment, likely resulting in a short-term price drop.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100